Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Canopy Growth | 702 | 2024q3 | |||||||||
Cardlytics | 130 | 2023q1 | |||||||||
Nikola Corp. | 3,106 | 2021 | |||||||||
Capricor Therapeutics | 154 | 2023q3 | |||||||||
BioAtla | 116 | 2023q3 | |||||||||
CV Sciences | 4 | 2021 | |||||||||
Sangamo Therapeutics | 91 | 2023q3 | |||||||||
Telo Genomics | 6 | 2022 | |||||||||
Jumia Technologies | 403 | 2024q2 | |||||||||
BrainStorm Cell Therapeut... | 21 | 2021 | |||||||||
Inovio Pharmaceuticals | 2,526 | 2021 | |||||||||
FibroGen | 33 | 2023q2 | |||||||||
Blink Charging | 231 | 2023q3 | |||||||||
Burning Rock Biotech | 774 | 2024q1 | |||||||||
Sage Therapeutics | 799 | 2023q3 | |||||||||
Shattuck Labs | 401 | 2023q3 | |||||||||
Quince Therapeutics | 24 | 2021 | |||||||||
Iovance Biotherapeutics | 2,756 | 2023q1 | |||||||||
Aytu BioPharma | 10 | 2022 | |||||||||
Canoo | 98 | 2021 |